BAC
Bank of America Corporation
BAC has a slight edge over UBSI overall, supported by stronger modeled upside and stronger fundamentals.
UBSI
United Bankshares, Inc.
UBSI's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
UBSI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
UBSI's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like UBSI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
UBSI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $43.13 | -9.9% |
| Forward | 12x | $47.86 | — |
| Fair | 13x | $47.68 | -0.4% |
| Current | 13x | $47.86 | — |
| Expensive | 15x | $53.85 | +13% |
Historical ranges are pointers, not guarantees.
UBSI has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
UBSI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for UBSI, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over UBSI on earnings, with stronger typical year-over-year growth.
UBSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.90 | +5.6% |
| Q3 2026 | $3.69 | +21% |
| Q2 2026 | $3.67 | +30% |
| Q1 2026 | $3.57 | +33% |
| Q4 2025 | $3.27 | +19% |
| Q3 2025 | $3.05 | +16% |
| Q2 2025 | $2.83 | +6.8% |
| Q1 2025 | $2.69 | +2.7% |
| Q4 2024 | $2.74 | +1.1% |
UBSI's earnings per share have climbed steadily: $3.69 over the past year, up 21% from the year before, and higher year over year for eight quarters in a row. Its recent earnings include one-off gains.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
UBSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $325.1M | +0.5% |
| Q2 2026 | $323.8M | +5.8% |
| Q1 2026 | $316.6M | +9.3% |
| Q4 2025 | $318.4M | +22% |
| Q3 2025 | $323.3M | +23% |
| Q2 2025 | $306M | +20% |
| Q1 2025 | $289.6M | +14% |
| Q4 2024 | $261.9M | -0.5% |
UBSI's revenue has grown year over year for seven quarters in a row: $325M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | -1 points |
| Q2 2026 | 51% | +1 points |
| Q1 2026 | 49% | +12 points |
| Q4 2025 | 50% | +4 points |
| Q3 2025 | 51% | +5.1 points |
| Q2 2025 | 50% | +4.6 points |
| Q1 2025 | 37% | -5.6 points |
| Q4 2024 | 46% | +6.6 points |
UBSI has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
UBSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $162.7M | +11% |
| Q2 2026 | $98M | +15% |
| Q1 2026 | $156M | +34% |
| Q4 2025 | $133.5M | 0% |
| Q3 2025 | $146.4M | +20% |
| Q2 2025 | $85.2M | +46% |
| Q1 2025 | $116.1M | -2.9% |
| Q4 2024 | $133.5M | -16% |
UBSI has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over UBSI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
UBSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -1.4M shares |
| 1 year | -3.5% | -4.9M shares |
| 3 years | +1.6% | +2.1M shares |
| 5 years | +6.3% | +8.1M shares |
| Available history | +35% | +35.5M shares |
UBSI has 137M diluted shares, down 3.5% from a year ago, with $283M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $98.8M |
| Q2 2026 | $66M |
| Q1 2026 | $70.3M |
| Q4 2025 | $47.6M |
| Q3 2025 | $26.5M |
| Q2 2025 | $32.6M |
| Q1 2025 | $20.3M |
| Q4 2024 | — |
UBSI spent $283M buying back its own shares over the past year, about four times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
UBSI Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
UBSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 60.1 | Neutral |
UBSI's weekly RSI is 58 (neutral) and its Stochastic is 60 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over UBSI on valuation relative to its sector.
UBSI PE vs Financial Services Sector
| Metric | UBSI | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.4% below |
| PE % | 50 | 63 | 13 pts below |
UBSI is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
UBSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.4 | 1% above |
| 20 week MA | $47.5 | 0.7% above |
| 50 week MA | $44.3 | 8% above |
| 100 week MA | $40.3 | 19% above |
| 200 week MA | $37.4 | 28% above |
UBSI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
UBSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.4 | $31.9 | -17% |
| 2021 | $31.9 | $36.0 | +13% |
| 2022 | $36.0 | $40.5 | +12% |
| 2023 | $40.5 | $37.6 | -7.2% |
| 2024 | $37.6 | $37.9 | +0.9% |
| 2025 | $37.9 | $39.5 | +4.3% |
| 2026 YTD | $39.5 | $47.9 | +21% |
UBSI has the edge over BAC on returns for 2026, with the stronger performance.